u/Keeg117 · 240d agono track record yet
Long GANX
Gain Therapeutics ($GANX) - The Parkinson's 'Unicorn' the biotech market is sleeping on. Clinical proof of disease reversal and a major catalyst on 3/17.
Gain Therapeutics is developing the first drug to reverse Parkinson's disease, backed by human data showing 81% reduction in brain toxins and significant physical recovery in 90 days. With a $100M market cap and major catalysts on 3/17–18, analysts project 400%+ upside with potential for multi-billion dollar buyout.
At post $2.51Now $1.13-55.0% since postedas of Oct 30, 4:45 PM ET
1d+21.5%
3d+21.5%
1w+9.6%
1m-26.3%
3m-28.7%
6m-29.5%
1y—